Arcus Biosciences (RCUS)
(Real Time Quote from BATS)
$14.28 USD
+0.28 (2.00%)
Updated Aug 8, 2024 09:40 AM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | *AMC8/8/24 |
---|---|
Current Quarter | -1.02 |
EPS Last Quarter | -0.05 |
Last EPS Surprise | 94.85% |
ABR | 1.20 |
Earnings ESP
|
0.32% |
---|---|
Current Year | -3.07 |
Next Year | -3.94 |
EPS (TTM) | -3.11 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 30.93M | 64.73M | 272.10M | 94.34M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 32.80M | 130.00M | 335.00M | 153.02M |
Low Estimate | 30.00M | 30.00M | 235.00M | 30.00M |
Year ago Sales | 29.00M | 32.00M | 117.00M | 272.10M |
Year over Year Growth Est. | 6.67% | 102.29% | 132.56% | -65.33% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.02 | -0.63 | -3.07 | -3.94 |
# of Estimates | 3 | 3 | 6 | 5 |
Most Recent Consensus | -0.88 | -0.70 | -3.10 | -2.41 |
High Estimate | -0.88 | -0.14 | -2.35 | -2.41 |
Low Estimate | -1.17 | -1.06 | -3.81 | -6.37 |
Year ago EPS | -1.04 | -0.94 | -4.15 | -3.07 |
Year over Year Growth Est. | 1.92% | 32.98% | 26.02% | -28.30% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.02 | -0.63 | -3.07 | -3.94 |
7 Days Ago | -1.02 | -0.63 | -3.07 | -3.94 |
30 Days Ago | -1.01 | -0.61 | -2.61 | -3.98 |
60 Days Ago | -1.04 | -0.99 | -3.02 | -3.64 |
90 Days Ago | 0.02 | -1.02 | -3.18 | -3.96 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.02 | -1.06 | -3.11 | -4.21 |
Zacks Consensus Estimate | -1.02 | -0.63 | -3.07 | -3.94 |
Earnings ESP | 0.32% | -67.37% | -1.19% | -6.80% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.05 | -1.08 | -0.94 | -1.04 | NA |
Estimate | -0.97 | -1.09 | -1.12 | -1.00 | NA |
Difference | 0.92 | 0.01 | 0.18 | -0.04 | 0.27 |
Surprise | 94.85% | 0.92% | 16.07% | -4.00% | 26.96% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more